US › Healthcare

MapLight Therapeutics, Inc. Common Stock (MPLT)

US · Healthcare · Biotechnology

$12.94+3.11%

Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue

Net profit

$-60.7M

Profit YoY

-171.6%

EPS

$-1.34

EPS estimate

$-1.09

EPS came in at -1.34 against a street estimate of -1.09 — a miss of 22.9%.

Key statistics

Market cap

$590.4M

Forward P/E

0.0

P/B

1.48

Book value

$8.84

EPS (TTM)

$-4.41

52-week high

$40.43

52-week low

$9.10

50-day MA

$30.49

200-day MA

$22.72

Analyst view

with an average price target of $32.31.

Shareholding

Insiders

51.65%

Institutions

57.00%

Largest institutional holders

Fund	Stake
Novo A/S	8.13%
FCPM III SERVICES BV	7.12%
T. Rowe Price Investment Management,Inc.	6.18%
The Goldman Sachs Group Inc	4.40%
BlackRock Inc	2.95%
Blue Owl Capital Holdings LP	2.22%
Nan Fung Group Holdings Ltd	2.14%
5AM Venture Management, LLC	2.10%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for MapLight Therapeutics, Inc. Common Stock — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc UnitedHealth Group Incorporated Merck & Company Inc Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Novo Nordisk A/S Amgen Inc Abbott Laboratories Gilead Sciences Inc

Data updated 2026-08-05.